Furthermore, to visualize the association between GNG5 expression and IDH mutation in clinical samples, we performed IHC staining on clinical samples, which showed a significant correlation between IDH mutation and GNG5 expression levels in gliomas (Table 1, Additional file 5: Figure S2). The gene discussed is GNG5; the disease is central nervous system cancer.